OTC · Financial Statements

Bio Essence Corporation (BIOE) Financial Statements

$0.25 OTC: BIOE Market Cap $9.90M

Bio Essence Corporation most recently reported annual revenue of $2.0M, net profit of $1.0M, revenue has compounded at 14.9% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$0$2.0M
Operating Profit$-1.0M$-1.0M$-1.0M$0$1.0M
Net Profit$-1.0M$-1.0M$-1.0M$-1.0M$1.0M
EPS$-0.02$-0.02$-0.02$-0.03$0.02
Op Margin-96.6%-82.2%-143.1%-141.8%47.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0M$2.0M$3.0M$0$0
Total Liabilities$4.0M$5.0M$4.0M$3.0M$2.0M
Cash$0$0$0$0$0
Borrowings$4.0M$5.0M$3.0M$3.0M$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-1.0M$1.0M$2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$1.0M$1.0M$0$0$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$-1.0M$-1.0M$-1.0M$1.0M$2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA8.65
FCF Yield11.96%
Quick Ratio0.37
Interest Coverage604.53
Return 1Y121.24%
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
BIOE Overview BIOE Dividend Run Stock Screener